Table 3 Rescue medication use during the AOM 400 maintenance phase
Medication | Enrollment source | Number of patients | Number (%) taking rescue medication | Duration (days)a | ||
|---|---|---|---|---|---|---|
Mean | SD | Median | ||||
Lithium | De novo | 379 | 28 (7.4) | 147.9 | 101.8 | 131.5 |
Rollover | 85 | 0 | – | – | – | |
Total | 464 | 28 (6.0) | 147.9 | 101.8 | 131.5 | |
Valproate | De novo | 379 | 35 (9.2) | 114.5 | 96.6 | 100 |
Rollover | 85 | 1 (1.2) | 84.0 | – | 84.0 | |
Total | 464 | 36 (7.8) | 113.7 | 95.4 | 92.0 | |